Nicolas Carlier

4.7k total citations
18 papers, 175 citations indexed

About

Nicolas Carlier is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Nicolas Carlier has authored 18 papers receiving a total of 175 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Neurology. Recurrent topics in Nicolas Carlier's work include COVID-19 Clinical Research Studies (6 papers), Cystic Fibrosis Research Advances (4 papers) and Long-Term Effects of COVID-19 (4 papers). Nicolas Carlier is often cited by papers focused on COVID-19 Clinical Research Studies (6 papers), Cystic Fibrosis Research Advances (4 papers) and Long-Term Effects of COVID-19 (4 papers). Nicolas Carlier collaborates with scholars based in France, United States and Italy. Nicolas Carlier's co-authors include Benjamin Terrier, Frédéric Pène, Didier Borderie, Camille Chenevier‐Gobeaux, Nicolas Chapuis, Tali‐Anne Szwebel, Nicolás Roche, Jean–François Méritet, Solen Kernéis and Frédéric Rieux‐Laucat and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Journal of Allergy and Clinical Immunology.

In The Last Decade

Nicolas Carlier

15 papers receiving 173 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolas Carlier France 9 81 42 41 27 24 18 175
Stefania Notari Italy 8 107 1.3× 35 0.8× 44 1.1× 16 0.6× 14 0.6× 18 192
Jason L. Floyd United States 8 63 0.8× 157 3.7× 30 0.7× 24 0.9× 8 0.3× 12 287
Suruchi Garg India 7 67 0.8× 20 0.5× 125 3.0× 10 0.4× 19 0.8× 21 298
Sara Hasler Switzerland 4 126 1.6× 39 0.9× 161 3.9× 10 0.4× 12 0.5× 4 222
Michael Celinski United Kingdom 6 78 1.0× 15 0.4× 62 1.5× 49 1.8× 29 1.2× 10 180
Jonathan Edgeworth United Kingdom 7 66 0.8× 52 1.2× 19 0.5× 72 2.7× 7 0.3× 15 204
Konstantina Katrini Greece 5 29 0.4× 35 0.8× 21 0.5× 21 0.8× 18 0.8× 6 123
Rafael León‐López Spain 7 29 0.4× 16 0.4× 61 1.5× 13 0.5× 15 0.6× 10 146
Larissa E. van Eijk Netherlands 4 100 1.2× 35 0.8× 68 1.7× 21 0.8× 16 0.7× 9 174
Kehong Lou China 4 248 3.1× 33 0.8× 152 3.7× 53 2.0× 17 0.7× 4 328

Countries citing papers authored by Nicolas Carlier

Since Specialization
Citations

This map shows the geographic impact of Nicolas Carlier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Carlier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Carlier more than expected).

Fields of papers citing papers by Nicolas Carlier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Carlier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Carlier. The network helps show where Nicolas Carlier may publish in the future.

Co-authorship network of co-authors of Nicolas Carlier

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Carlier. A scholar is included among the top collaborators of Nicolas Carlier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Carlier. Nicolas Carlier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Chassagnon, Guillaume, Jennifer Da Silva, Isabelle Honoré, et al.. (2025). Identification of structural predictors of lung function improvement in adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor using deep-learning. Diagnostic and Interventional Imaging. 107(2). 62–72.
2.
Bouazza, Naïm, Frantz Foissac, Gabrielle Lui, et al.. (2025). Population Pharmacokinetics of Elexacaftor, Tezacaftor and Ivacaftor in a Real-World Cohort of Adults with Cystic Fibrosis. Clinical Pharmacokinetics. 64(6). 959–971.
3.
Chassagnon, Guillaume, Jennifer Da Silva, Reem Kanaan, et al.. (2024). Reversal of cylindrical bronchial dilatations in a subset of adults with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor. European Respiratory Journal. 63(3). 2301794–2301794. 10 indexed citations
4.
Armignacco, Roberta, Nicolas Carlier, Anne Jouinot, et al.. (2024). Whole blood transcriptome signature predicts severe forms of COVID-19: Results from the COVIDeF cohort study. Functional & Integrative Genomics. 24(3). 107–107. 3 indexed citations
5.
Daste, Camille, Alexandra Rören, Nicolas Carlier, et al.. (2023). Early shoulder-girdle MRI findings in severe COVID-19–related intensive care unit-acquired weakness: a prospective cohort study. European Radiology. 33(7). 4994–5006. 2 indexed citations
6.
Dauriat, Gaëlle, L. Beaumont, Liêm Binh Luong Nguyen, et al.. (2022). Efficacy of three COVID-19 vaccine doses in lung transplant recipients: a multicentre cohort study. European Respiratory Journal. 61(1). 2200502–2200502. 16 indexed citations
7.
Chenevier‐Gobeaux, Camille, Jean–François Méritet, Nicolas Chapuis, et al.. (2022). Plasma Endocan as a Biomarker of Thrombotic Events in COVID-19 Patients. Journal of Clinical Medicine. 11(19). 5560–5560. 8 indexed citations
8.
Boussier, Jérémy, Nader Yatim, A. Marchal, et al.. (2021). Severe COVID-19 is associated with hyperactivation of the alternative complement pathway. Journal of Allergy and Clinical Immunology. 149(2). 550–556.e2. 25 indexed citations
9.
Coriati, Adèle, Jenna Sykes, Lydie Lemonnier, et al.. (2021). Impact of a high emergency lung transplantation programme for cystic fibrosis in France: insight from a comparison with Canada. European Respiratory Journal. 59(1). 2100014–2100014. 9 indexed citations
10.
Courties, Alice, Jérémy Boussier, Jérôme Hadjadj, et al.. (2021). Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients. Scientific Reports. 11(1). 11886–11886. 31 indexed citations
11.
Chenevier‐Gobeaux, Camille, Jean–François Méritet, Nicolas Chapuis, et al.. (2021). Oxidative Stress and Inflammatory Biomarkers for the Prediction of Severity and ICU Admission in Unselected Patients Hospitalized with COVID-19. International Journal of Molecular Sciences. 22(14). 7462–7462. 47 indexed citations
12.
Chouchana, Laurent, Inès Gana, Lucile Regard, et al.. (2020). Plasma Concentrations and Safety of Lopinavir/Ritonavir in COVID-19 Patients. Therapeutic Drug Monitoring. 43(1). 131–135. 9 indexed citations
13.
Tordjman, Mickaël, Ahmed Mekki, Guillaume Chassagnon, et al.. (2020). Determining extent of COVID-19 pneumonia on CT based on biological variables. Respiratory Medicine. 175. 106206–106206. 9 indexed citations
14.
Carlier, Nicolas, et al.. (2020). Affections aspergillaires respiratoires et BPCO : difficultés diagnostiques. Revue des Maladies Respiratoires. 37(4). 308–319. 2 indexed citations
15.
Burnet, Espérie, et al.. (2020). P351 The introduction of Advanced Nursing Practice in French cystic fibrosis centres faces many challenges and opportunities. Journal of Cystic Fibrosis. 19. S154–S154. 1 indexed citations
16.
Burgel, Pierre‐Régis, Cécile Hamard, Nicolas Carlier, et al.. (2014). 292 Specific causes of mortality in CF patients in France 2007-2010. Journal of Cystic Fibrosis. 13. S123–S123. 1 indexed citations
17.
Carlier, Nicolas, et al.. (2014). Un nouveau rôle potentiel de Human Airway Trypsin-like protease dans la fibrose pulmonaire. Revue des Maladies Respiratoires. 31(7). 673–674.
18.
Prost, A., et al.. (1978). [Fluorine osteosis caused by a very long-term niflumic acid treatment in 2 cases of rheumatoid arthritis].. PubMed. 45(12). 707–16. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefania Notari Breakdown of academic impact, for papers by Jason L. Floyd Breakdown of academic impact, for papers by Suruchi Garg Breakdown of academic impact, for papers by Sara Hasler Breakdown of academic impact, for papers by Michael Celinski Breakdown of academic impact, for papers by Jonathan Edgeworth Breakdown of academic impact, for papers by Konstantina Katrini Breakdown of academic impact, for papers by Rafael León‐López Breakdown of academic impact, for papers by Larissa E. van Eijk Breakdown of academic impact, for papers by Kehong Lou
Rankless by CCL
2026